STTK (Shattuck Labs) Short-Term Debt to Capital
The market price visualization for Shattuck Labs, Inc. (STTK) demonstrates a debt-to-equity ratio of 0.00. The business relies on automated systems for the rapid analysis of anti-tumor proteins, eliminating manual labor. However, external conflicts are blocking raw material logistics and global testing. High clinical trial expenses create significant operating leverage, keeping returns at a low level.
Analytical breakdowns for Shattuck Labs, Inc.
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
Total Debt to Capital Shattuck Labs, Inc.|STTK - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Shattuck Labs, Inc.|STTK - Aggregate Debt Obligations|Debts to Book Capitalization Shattuck Labs Inc|STTK - Long-Term Debt Volume|Company Short-Term Debt Shattuck Labs|Quick Liquidity shattucklabs.com
- company profitability and valuation multiples indicators:
Fundamental valuation:Shattuck Labs
The potential of Shattuck Labs, Inc. (STTK) in leukemia therapy requires significant investment prior to Phase 2 trials, making liquidity control critical. By analyzing the ratio of current liabilities to equity on GURU.Markets, an investor assesses the share of short-term borrowing within the equity structure; a decrease in this ratio minimizes default risk, confirming the company's financial stability while awaiting new licensing partnerships.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Nektar Corp|Short-Term Debt to Equity Upstream Bio Inc (UPB)|zenasbio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Current Liabilities to Capital|KALV - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient Septerna Pharma SEPN|PVLA: Short-Term Debt to Capital|savarapharma.com - Ratio of Short-Term Indebtedness to Capital|RIGL (Rigel Pharmaceuticals, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital AnaptysBio Inc|Short-Term Debt to Equity Ratio ATXS (Astria Pharma)|Short-Term Loans to Capital Ratio ENGN|RAPT Therapeutics - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio JBIO (Aerovate Therapeutics, Inc.)|ACRS: Short-Term Debt to Equity Ratio|KYTX - Short-Term Debt to Capital|TLSA: Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Cabaletta Bio Inc|Short-Term Debt to Equity Ventyx Biosciences|Short-Term Debt to Capital theratech.com|Short-Term Debt to Equity Ratio AVTX (Avalo Therapeutics)|ELDN (Eledon Pharmaceuticals Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Agenus Inc AGEN|Climb Bio, Inc - Short-Term Debt to Equity|Zura Bio - Short-Term Debt to Capital|ATYR - Short-Term Debt to Capital|ADAG: Short-Term Debt to Capital|IMA (Ikena Oncology) - Short-Term Debt to Equity|Short-Term Debt to Equity Equillium Inc|Connect Pharma (CNTB) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio IMUX (Immunic, Inc.)|ATRA (atarabio.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital IFRX (InflaRx)|Short-Term Debt to Capital Coefficient X4 Pharmaceuticals Inc. (XFOR)|ACET - Short-Term Debt to Equity|CELU (Celularity Inc.) - Short-Term Debt to Capital Ratio|INMB: Short-Term Debt to Capital|Short-Term Debt to Equity Ratio barinthusbio.com|Short-Term Debt to Equity Ratio KZR|SAB Biotherapeutics Inc. (SABS) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Akari Therapeutics plc (AKTX)|Short-Term Debt to Capital Coefficient enlivex.com|Q32 Bio - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio GOVX (geovax.com)|EDSA: Short-Term Debt to Equity Ratio|iBio Inc - Short-Term Loans to Capital Ratio|carismatx.com (CARM) - Short-Term Debt to Equity|XTL Bio (XTLB) - Short-Term Debt to Capital|Short-Term Debt to Equity Bolt Biotherapeutics Inc.|HCW Biologics Inc - Current Liabilities to Equity|Short-Term Debt to Capital APVO|AIM (aimimmuno.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ADTX (Aditxt, Inc.)|Short-Term Debt to Capital GRI Bio Corporation GRI|XRTX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital HIND (reshapelifesciences.com)|Revelation Biosciences, Inc. (REVB) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Indaptus Therapeutics Inc|SCNI (Scinai) - Short-Term Debt to Capital|Short-Term Debt to Capital CalciMedica Corp|Short-Term Debt to Equity Ratio AFMD (Affimed)|ALLK (allakos.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital HOOK (HOOKIPA Pharma)|Short-Term Debt to Capital Coefficient IGM Biosciences Inc. (IGMS)|ITOS - Short-Term Debt to Equity|Ocean Biomedical Corp (OCEA) - Short-Term Debt to Equity Ratio|TC Biopharm (TCBP) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio thirdharmonicbio.com